[indiabio]

The new govt's Make In India initiative will focus on the biotech industry as well, it seems.
I noticed some interesting and promising statistics on the website, with regard to investing in India's robust biotech industry:

• India is amongst the top 12 biotech destinations in the world and ranks third in the Asia-Pacific region.
  
• India has the second-highest number of USFDA–approved plants, after the USA.
  
• India adopted the product patent regime in 2005.
  
• Increasing government expenditure will augment the growth of the sector — the government aims to spend USD 3.7 Billion on biotechnology between 2012-17.
  
• India is the largest producer of recombinant Hepatitis B vaccine.
  
• 3rd biggest biotech industry in the Asia-Pacific region.
  
• 2nd highest number of USFDA–approved plants.
  
• USD 3.7 Billion to be spent on biotechnology from 2012-17.
  
• No. 1 producer of Hepatitis B vaccine recombinant.
  
• USD 4.3 Billion bio-economy by the end of 2013.
  
• USD 100 Billion industry by 2025.
  

The data is even more encouraging as the govt offers Foreign Direct Investment (FDI) up to 100% is permitted through the automatic route for greenfield and through the government route for brownfield, for pharmaceuticals.

Hope to see this initiative result in a more robust industry, creating opportunities for many. India needs a strong pool of engineers, scientists and biotech professionals to separ head the growth of this industry. More information on this can be found on the Make in India website. 

Any thoughts, ideas, criticisms are welcome.